Breitfeld Philip P. 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Nov 7, 2023
Insider Transaction Report
Form 4
Breitfeld Philip P.
Director
Transactions
- Award
Option to purchase Common Stock
2023-11-03$5.51/sh+15,495$85,377→ 15,495 totalExercise: $5.51Exp: 2033-11-03→ Common Stock (15,495 underlying)
Footnotes (1)
- [F1]The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively.